Bill114th CongressFiled May 19, 2015Health
H.R. 2452
To amend the Federal Food, Drug, and Cosmetic Act with respect to facilitating dissemination of health care economic information.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (May 19, 2015)
This bill amends the Federal Food, Drug, and Cosmetic Act to revise the requirements for health care economic information that is provided to entities selecting drugs for coverage or reimbursement, such as formularies. The information must include a conspicuous and prominent statement describing the differences between the information and the labeling approved for the drug.
"Health care economic information" is an analysis that describes the economic consequences of the use of a drug. Such an analysis is no longer required to compare the use of the drug to another intervention or no intervention. An analysis that relates only to an indication for which the drug is not approved is not health care economic information.What just happenedMay 22, 2015
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Long, Billy [R-MO-7](R-MO)Sponsor
2 cosponsors1 D1 R
2cosponsors1committees4actions2related bills2subjects
- Introduced in HouseMay 19, 2015
- May 22, 2015Committee
Referred to the Subcommittee on Health.
Health Subcommittee - May 19, 2015IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - May 19, 2015IntroReferralIntro-H
Introduced in House
- May 19, 2015IntroReferral1000
Introduced in House